E N D
3. Hemostasis:
4. Hemostasis:Hemo/Stasis
Hemo=???
Stasis=????
5. ???? ???????:
6. Causes of Bleeding(1)Thrombocytopenia: Primary:
ITP
Neonatal Isoimmune
TAR Syndrome
Wiskott-Aldrich Syn. Secondary:
*Malignancy
*Aplastic Anemia
*DIC
*Sepsis
*HUS
*Hypersplenism
*Autoimmune(SLE)
7. Causes of Bleeding(2)Coagulopathy: Primary:
vWF Deficiency
Hemophilia
Platelet dysfunction Secondary:
DIC
Anticoagulants
Vit K deficiency
Hepatic Failure
Renal Failure
Maternal Anticonvulsant
8. Causes of Bleeding(3)Vascular(Non-Hematologic) Child Abuse
Vasculitis
Ulcer
Varices
Ehlers-Danlos Syndrome
Telangiectasia
Angiodysplasia
9. ????? ???? ???????: 1)??????? ?????:??? ????? ??? ?? ???? ????? ????? ????? ? ?? ??????? ?? ???? ???? ? ?????? ??????? ?????.
2)??????? ??????:??? ????? ??? ?? ???? ????? ????? ????? ? ?? ??????? ?? ???? ???? ??????? ?????.
11. Differences of Primary and Secondary Hemostasis:
16. Estimation of BT with desired Platelet count
BT= 30.5- Platelet count (minute)
3,850
24. Vitamin K Related Factors: Factor II
Factor VII
Factor IX
Factor X
26. Prolonged PTT No clinical bleeding
???
Mild or rare bleeding
???
Frequent,Severe Bleeding
???
28. Prolonged PTT No clinical bleeding
Factor XII , HMWK , PK
Mild or rare bleeding
Factor XI
Frequent,Severe Bleeding
Factors VIII and IX
29. Prolonged PT ???
???
???
31. Prolonged PT Factor VII Deficiency
Vitamin K Deficiency(Early)
Warfarin anticoagulant ingestion
32. Prolonged PT and PTT ???
???
???
34. Prolonged PT and PTT Factor II,V,X Deficiency
Vitamin K Deficiency(Late)
Warfarin anticoagulant ingestion
35. Prolonged TT ???
???
???
37. Prolonged TT Mild or rare bleeding: Afibrinogenemia
Frequent,Severe Bleeding:Dysfibrinogenemia
Heparin like inhibitors or heparin administration
38. Prolonged PT and/or PTT not corrected with normal plasma Specific or nonspecific inhibitor Syndromes
39. Clot Solubility in 5 M urea Factor XIII deficiency
Inhibitor
41. Secondary Hemostasis Approach: 1)What is diagnosis?
2)What is hemostatic level of Factor?
3)What is blood distribution of factor?
4)Which products contain desired factor?
5)What is half life of coagulation factor?
46. APPROACH TO COAGULATION DISORDERS
47. Clinical approach 1. Is the bleeding significant ?
2. Local Vs Systemic ?
3. Platelet Vs Coagulation disorder ?
4. Inherited Vs Acquired ?
48. 1. Demonstration of the defect
2. Identification of the defect(s)
3. Assessment of severity
4. Consequential studies eg. carrier detection
5. Monitoring of treatment
Laboratory Approach
49. 1. Platelet count & morphology
2. Bleeding Time(BT)
3. Prothrombin Time(PT)
4. Activated Partial Thromboplastin Time(PTT)
5. Thrombin Time (TT)
Screening Tests
50. Collection of blood sample 1. Minimum circulatory stasis
2. Clean venous puncture
3. Proper anticoagulant
4. Proportion of blood to anticoagulant
5. Separation of plasma and storage
6. Effect of stress, pregnancy, drugs
7. Effect of PCV on the proportion of plasma to anticoagulant
51. Coagulation factor deficiency/inhibitor
Test plus control plasma - 1:1
Repeat PT/APTT
> 50% correction
Yes - Factor deficiency
No - inhibitor Prolonged PT/APTT
62. Factor XIII deficiency
Thrombasthenia
congenital
drug induced
Disorders of vascular hemostasis
Factor XIII - clot solubility PT, APTT, TT, PLC - Normal Platelet function
BT
clot retraction
1 minute platelet count
aggregation
Tourniquet test
63. Asymptomatic Patient Routine screening tests shows prolonged APTT
Inhibitor - lupus anticoagulant
Factor XII deficiency
Mild congenital factor deficiency
64. Antiphospholipid Antibody SyndromeCriteria by Branch and Silver 1996 Clinical
Recurrent abortion
Recurrent venous thrombosis
Recurrent arterial thrombosis
Persistent thrombocytopenia
Livedo reticularis
Laboratory
IgG/IgM anticardiolipin Ab
Lupus anticoagulant
Diagnosis
1 clinical + 1 lab criteria
Lab result must be positive on at least 2 occasions more than 3 months apart
65. Kaolin clotting time
Dilute Russel’s viper venom time
Platelet neutralization test
Tissue thromboplastin inhibition test Lupus Anticoagulant